We present a mathematical model, based on ordinary differential equations, for the evolution of solid tumors and their response to treatment. Specifically the effects of a cytotoxic agent and a monoclonal antibody are included as control term in the equations. The variables considered here are: the number of cancerous cells sensitive to chemotherapy, the number of cancerous cells resistant to chemotherapy, the degree of angiogenesis and the average intensity of VEGF. The rules that govern the quantities mentioned above are based on a geometrical argument: we approximate the tumor mass as a sphere and thus derive basic formulae for the normoxic cells and for VEGF production. The monoclonal antibody acts on VEGF and thus has in uence to the global degree of angiogenesis. Numerical estimates on some of the parameters are performed in order to match the main landmark in tumor progression and reaction to treatment in the specific case of colorectal cancer.
Rigorous results of limiting behaviors of total tumor size under cyclic intermittent therapy for the system of reversible phenotype-switchable tumor cells
Robust multicellular programs dissect the complex tumor microenvironment and track disease progression in colorectal adenocarcinomas
German Cancer Research Center (DKFZ)(德国癌症研究中心);Heidelberg University(海德堡大学);Heidelberg University Hospital(海德堡大学医院);University Medical Center Hamburg-Eppendorf(汉堡埃彭多夫大学医学中心);European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI)(欧洲分子生物学实验室,欧洲生物信息学研究所);German Cancer Consortium (DKTK)(德国癌症联盟)
CRC-ICM: Colorectal Cancer Immune Cell Markers Pattern Dataset
Isfahan University of Medical Sciences(伊斯法罕医科大学);Poursina Hakim Digestive Diseases Research Center, Isfahan University of Medical Sciences(伊斯法罕医科大学普尔西纳哈基姆消化系统疾病研究中心);Islamic Azad University(伊斯兰阿扎德大学);Shiraz University of Medical Sciences(设拉子医科大学)
Novel digital tissue phenotypic signatures of distant metastasis in colorectal cancer
University of Oxford(牛津大学);University Hospitals Coventry and Warwickshire(考文垂与沃里克郡大学医院);University of Warwick(华威大学);Hamad Medical Corporation(哈马德医疗公司);International Association for Cancer Research(国际癌症研究协会)
A general framework for modeling tumor-immune system competition and immunotherapy: mathematical analysis and biomedical inferences
在这项工作中,我们提出并研究了一个家庭的模型,其中承认作为特殊情况下,一些众所周知的肿瘤免疫系统相互作用的数学模型,与额外的假设,即免疫系统细胞的流入可能是癌细胞的数量的函数。常数,周期和脉冲疗法(以及非扰动系统)的研究分析一般家庭,并通过使用模型Kuznetsov等人。库兹涅佐夫岛A. Makalkin,M. A. Taylor和A. S.佩雷尔森免疫原性肿瘤的非线性动力学:参数估计和全局分叉分析。Bulletin of Mathematical Biology 56(2):295-321,(1994))。模拟似乎表明,对治疗进行建模的函数的形状仅对于非常高的治疗期$T$值是关键因素,而对于$T$的实际值,癌细胞的根除取决于治疗期的平均值。最后,提出了一些医学推论。
Optimisation of neoadjuvant pembrolizumab therapy for locally advanced MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations
School of Mathematics and Statistics, University of Sydney(悉尼大学数学与统计学院);Department of Immuno-Oncology, Beckman Research Institute, City of Hope(希科医院贝克曼研究所免疫肿瘤学系)
A stochastic agent-based model for simulating tumor-immune dynamics and evaluating therapeutic strategies
School of Software, Tiangong University(天津工业大学软件学院);School of Mathematical Sciences, Tiangong University(天津工业大学数学科学学院);Center for Applied Mathematics, Tiangong University(天津工业大学应用数学中心)
Patient-specific, mechanistic models of tumor growth incorporating artificial intelligence and big data
University of Pavia(帕维亚大学);The University of Texas at Austin(德克萨斯大学奥斯汀分校);Oden Institute for Computational Engineering and Sciences(奥登计算工程与科学研究所);Massachusetts General Hospital(麻省总医院);Harvard Medical School(哈佛医学院);Harvard University(哈佛大学);Massachusetts Institute of Technology(麻省理工学院);Dartmouth College(达特茅斯学院);Geisel School of Medicine at Dartmouth(达特茅斯盖泽尔医学院);Livestrong Cancer Institutes(利文斯顿癌症研究所);Purdue University(普渡大学);Weldon School of Biomedical Engineering(韦尔登生物医学工程学院);University of Colorado Anschutz(科罗拉多大学安舒茨分校)